About
Zilico Limited is a private company based in Manchester, UK, established in February 2006. It was formed through a collaboration between the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust, with a focus on improving diagnostic accuracy for cervical intraepithelial neoplasia (CIN). The company specializes in the manufacture of medical and dental instruments and supplies, as well as engaging in specialist medical practice activities. Zilico's core technology is based on patented Electrical Impedance Spectroscopy (EIS), which is utilized in its flagship product, ZedScan. This diagnostic system works alongside colposcopy to provide real-time assessments of cervical tissue, enhancing the detection of cervical disease and supporting clinicians in making informed decisions regarding patient care. Zilico's products are aimed at healthcare providers involved in cervical cancer screening and diagnosis, including hospitals and specialist clinics. The company's technology is designed to deliver accurate diagnostic information, potentially leading to earlier and more effective treatment options for cervical cancer and other related conditions.
Technologies
Keywords
Company Information
-
Employees 7
-
Founded 2006
-
Annual Revenue $9000000
-
Total Funding $19000000
Location
Pencroft Way, Manchester, England, United Kingdom, M15 6